Association between HMGB1 and COPD: A systematic review

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Gangemi, Sebastiano ^a   Casciaro, Marco ^a   Trapani, Giovanni ^b   Quartuccio, Sebastiano ^b   Navarra, Michele ^b   Pioggia, Giovanni ^c   Imbalzano, Egidio ^b  

^a Medical Oncology and Integrated Therapies   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ALARMIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MACROPHAGE ELASTASE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2;

BRONCHUS BIOPSY; CELL DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; IMMUNOLOCALIZATION; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; LUNG FUNCTION; LUNG LAVAGE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; REVIEW; SEX DIFFERENCE; SMOKING; SYSTEMATIC REVIEW; ANIMAL; PHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; HMGB1 PROTEIN; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84954306333     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/164913     Document Type: Review

References (45)

1. G. H. Goodwin and E. W. Johns, "Are the high mobility group non-histone chromosomal proteins associated with 'active' chromatin?" Biochimica et Biophysica Acta, vol. 519, no. 1, pp. 279-284, 1978.
2. D. Landsman and M. Bustin, "A signature for the HMG-1 box DNA-binding proteins, " BioEssays, vol. 15, no. 8, pp. 539-546, 1993.
3. H. W. Chung, J.-B. Lim, S. Jang, K. J. Lee, K. H. Park, and S. Y. Song, "Serum high mobility group box-1 is a powerful diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma, " Cancer Science, vol. 103, no. 9, pp. 1714-1721, 2012.
4. M. Romani, T. C. Rodman, G. Vidali, and M. Bustin, "Serological analysis of species specificity in the high mobility group chromosomal proteins, "The Journal of Biological Chemistry, vol. 254, no. 8, pp. 2918-2922, 1979.
5. M. E. Bianchi and A. Agresti, "HMG proteins: dynamic players in gene regulation and differentiation, " Current Opinion in Genetics and Development, vol. 15, no. 5, pp. 496-506, 2005.
6. R. Hock, T. Furusawa, T. Ueda, and M. Bustin, "HMG chromosomal proteins in development and disease, " Trends in Cell Biology, vol. 17, no. 2, pp. 72-79, 2007.
7. R. P. Samy and L. H. Lim, "DAMPs and influenza virus infection in ageing, " Ageing Research Reviews, vol. 24, pp. 83-97, 2015.
8. S. D. Pouwels, M. C. Nawijn, E. Bathoorn et al., "Increased serum levels of LL37, HMGB1 and S100A9 during exacerbation in COPD patients, " European Respiratory Journal, vol. 45, no. 5, pp. 1482-1485, 2015.
9. R. Kang, R. Chen, Q. Zhang et al., "HMGB1 in health and disease, " Molecular Aspects of Medicine, vol. 40, pp. 1-116, 2014.
10. D.Tang, T. R. Billiar, andM. T. Lotze, "A Janus tale of two active high mobility group box 1 (HMGB1) redox states, " Molecular Medicine, vol. 18, no. 10, pp. 1360-1362, 2012.
11. GOLD, "Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, " 2015, http://www.goldcopd.org/.
12. V. Kim, T. J. Rogers, and G. J. Criner, "New concepts in the pathobiology of chronic obstructive pulmonary disease, " Proceedings of the AmericanThoracic Society, vol. 5, no. 4, pp. 478-485, 2008.
13. A. Liberati, D. G. Altman, J. Tetzlaff et al., "The PRISMA statement for reporting systematic reviews andmeta-Analyses of studies that evaluate health care interventions: explanation and elaboration, " PLoS Medicine, vol. 6, no. 7, Article ID e1000100, 2009.
14. G.-H. Shang, C.-Q. Jia, H. Tian et al., "Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer, " Respiratory Medicine, vol. 103, no. 12, pp. 1949-1953, 2009.
15. N. Ferhani, S. Letuve, A. Kozhich et al., "Expression of highmobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease, " American Journal of Respiratory and Critical CareMedicine, vol. 181, no. 9, pp. 917-927, 2010.
16. C. Hou, H. Zhao, L. Liu et al., "High mobility group protein B1 (HMGB1) in asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls, "Molecular Medicine, vol. 17, no. 7-8, pp. 807-815, 2011.
17. F. S. Bezerra, S. S. Valença, K. M. P. Pires et al., "Longterm exposure to cigarette smoke impairs lung function and increases HMGB-1 expression in mice, " Respiratory Physiology and Neurobiology, vol. 177, no. 2, pp. 120-126, 2011.
18. H. Kanazawa, Y. Tochino, K. Asai, Y. Ichimaru, T. Watanabe, and K. Hirata, "Validity of HMGB1 measurement in epithelial lining fluid in patients withCOPD, "EuropeanJournal of Clinical Investigation, vol. 42, no. 4, pp. 419-426, 2012.
19. C. M. Wang, M. Jiang, and H. J. Wang, "Effect of NF-B inhibitor on high-mobility group protein B1 expression in a COPD rat model, " Molecular Medicine Reports, vol. 7, no. 2, pp. 499-502, 2013.
20. H.-K. Ko, W.-H. Hsu, C.-C. Hsieh, T.-C. Lien, T.-S. Lee, and Y. R. Kou, "High expression of high-mobility group box 1 in the blood and lungs is associated with the development of chronic obstructive pulmonary disease in smokers, " Respirology, vol. 19, no. 2, pp. 253-261, 2014.
21. Y. Zhang, S. Li, G.Wang et al., "Changes ofHMGB1 and sRAGE during the recovery of COPD exacerbation, " Journal ofThoracic Disease, vol. 6, no. 6, pp. 734-741, 2014.
22. D. Zabini, S. Crnkovic, H. Xu et al., "High-mobility group box-1 induces vascular remodelling processes via c-Jun activation, " Journal of Cellular and Molecular Medicine, vol. 19, no. 5, pp. 1151-1161, 2015.
23. A. Di Stefano, G. Caramori, A. Barczyk et al., "Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD, " Thorax, vol. 69, no. 6, pp. 516-524, 2014.
24. H. Iwamoto, J. Gao, V. Pulkkinen, T. Toljamo, P. Nieminen, and W. Mazur, "Soluble receptor for advanced glycation endproducts and progression of airway disease, " BMC Pulmonary Medicine, vol. 14, no. 1, article 68, 2014.
25. I. H. Heijink, S. D. Pouwels, C. Leijendekker et al., "Cigarette smoke-induced damage-Associated molecular pattern release from necrotic neutrophils triggers proinflammatory mediator release, " American Journal of Respiratory Cell and Molecular Biology, vol. 52, no. 5, pp. 554-562, 2015.
26. I. E. Dumitriu, P. Baruah, A. A. Manfredi, M. E. Bianchi, and P. Rovere-Querini, "HMGB1: guiding immunity from within, " Trends in Immunology, vol. 26, no. 7, pp. 381-387, 2005.
27. A. Evans, T. W. J. Lennard, and B. R. Davies, "High-mobility group protein 1(Y): metastasis-Associated or metastasisinducing?" Journal of Surgical Oncology, vol. 88, no. 2, pp. 86-99, 2004.
28. R. Palumbo, M. Sampaolesi, F. De Marchis et al., "Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation, " The Journal of Cell Biology, vol. 164, no. 3, pp. 441-449, 2004.
29. H. J. Huttunen, C. Fages, and H. Rauvala, "Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-B require the cytoplasmic domain of the receptor but different downstream signaling pathways, "The Journal of Biological Chemistry, vol. 274, no. 28, pp. 19919-19924, 1999.
30. S. P. Jong, F. Gamboni-Robertson, Q. He et al., "High mobility group box 1 protein interacts with multiple Toll-like receptors, " The American Journal of Physiology-Cell Physiology, vol. 290, no. 3, pp. C917-C924, 2006.
31. T. Sasahira, Y. Akama, K. Fujii, and H. Kuniyasu, "Expression of receptor for advanced glycation end products and HMGB1/amphoterin in colorectal adenomas, " Virchows Archiv, vol. 446, no. 4, pp. 411-415, 2005.
32. M. Takada, K. Hirata, T. Ajiki, Y. Suzuki, and Y. Kuroda, "Expression of Receptor for Advanced Glycation End products (RAGE) and MMP-9 in human pancreatic cancer cells, " Hepatogastroenterology, vol. 51, no. 58, pp. 928-930, 2004.
33. A. Taguchi, D. C. Blood, G. del Toro et al., "Blockade of RAGE-Amphoterin signalling suppresses tumour growth and metastases, " Nature, vol. 405, no. 6784, pp. 354-360, 2000.
34. B. Degryse, T. Bonaldi, P. Scaffidi et al., "The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells, " Journal of Cell Biology, vol. 152, no. 6, pp. 1197-1206, 2001.
35. R.DeMori, S. Straino, A.Di Carloet al., "Multiple effects of high mobility group box protein 1 in skeletal muscle regeneration, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 11, pp. 2377-2383, 2007.
36. S. Straino, A. Di Carlo, A.Mangoni et al., "High-mobility group box 1 protein in human andmurine skin: involvement in wound healing, " Journal of Investigative Dermatology, vol. 128, no. 6, pp. 1545-1553, 2008.
37. J. H. Youn, Y. J. Oh, E. S. Kim, J. E. Choi, and J.-S. Shin, "High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-Alpha production in human monocytes, " Journal of Immunology, vol. 180, no. 7, pp. 5067-5074, 2008.
38. Y. Sha, J. Zmijewski, Z. Xu, and E. Abraham, "HMGB1 develops enhanced proinflammatory activity by binding to cytokines, " Journal of Immunology, vol. 180, no. 4, pp. 2531-2537, 2008.
39. A. Bierhaus, P. M. Humpert, M. Morcos et al., "Understanding RAGE, the receptor for advanced glycation end products, " Journal ofMolecularMedicine, vol. 83, no. 11, pp. 876-886, 2005.
40. J. Brett, A. M. Schmidt, S. D. Yan et al., "Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues, " The American Journal of Pathology, vol. 143, no. 6, pp. 1699-1712, 1993.
41. P. Morbini, C. Villa, I. Campo, M. Zorzetto, S. Inghilleri, and M. Luisetti, "The receptor for advanced glycation end products and its ligands: A new inflammatory pathway in lung disease?" Modern Pathology, vol. 19, no. 11, pp. 1437-1445, 2006.
42. I. Ito, J. Fukazawa, and M. Yoshida, "Post-Translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils, " The Journal of Biological Chemistry, vol. 282, no. 22, pp. 16336-16344, 2007.
43. S. M. Rowe, P. L. Jackson, G. Liu et al., "Potential role of highmobility group box 1 in cystic fibrosis airway disease, " American Journal of Respiratory and Critical CareMedicine, vol. 178, no. 8, pp. 822-831, 2008.
44. O.O. Ojo, M. H. Ryu, A. Jha, H.Unruh, andA. J.Halayko, "High Mobility Group Box 1 (HMGB1) promotes extracellular matrix synthesis and wound repair in human bronchial epithelial cells, " The American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 309, no. 11, pp. L1354-L1366, 2015.
45. E. Mortaz, I. M. Adcock, F. L. M. Ricciardolo et al., "Anti-inflammatory Eeffects of Lactobacillus rahmnosus and bifidobacterium breve on cigarette smoke activated human macrophages, " PLoS ONE, vol. 10, no. 8, Article ID e0136455, 2015.